Joel Embiid: Everything you need to know

Joel Embiid

#21 C

Philadelphia 76ers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

27.6

10.8

3.7

1.6

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	38	38	31.6	26.9	7.7	3.9	1.2	0.6	2.9	10	1	1.4	4.2	33.3%	7.6	14.2	53.5%	9.0	18.3	48.9%	7.5	8.8	85.4%	2.0	5.7	2.2	1.4	+155	60.5%
2024-25	19	19	30.2	23.8	8.2	4.5	0.9	0.7	3.3	7	1	1.2	4.1	29.9%	6.2	12.5	49.2%	7.4	16.6	44.4%	7.8	8.9	88.2%	1.9	6.3	2.2	1.4	-57	58.0%
2023-24	39	39	33.6	34.7	11.0	5.6	1.7	1.2	3.8	30	2	1.4	3.6	38.8%	10.2	18.3	55.6%	11.5	21.8	52.9%	10.2	11.6	88.3%	2.4	8.6	2.9	1.5	+267	64.4%
2022-23	66	66	34.6	33.1	10.2	4.2	1.7	1.0	3.4	39	1	1.0	3.0	33.0%	10.0	17.1	58.7%	11.0	20.1	54.8%	10.0	11.7	85.7%	1.7	8.4	3.1	1.2	+424	65.5%
2021-22	68	68	33.8	30.6	11.7	4.2	1.5	1.1	3.1	46	2	1.4	3.7	37.1%	8.4	15.9	52.9%	9.8	19.6	49.9%	9.6	11.8	81.4%	2.1	9.6	2.7	1.3	+367	61.6%
2020-21	51	51	31.1	28.5	10.6	2.8	1.4	1.0	3.1	31	0	1.1	3.0	37.7%	7.9	14.6	54.1%	9.0	17.6	51.3%	9.2	10.7	85.9%	2.2	8.4	2.4	0.9	+405	63.6%
2019-20	51	51	29.5	23.0	11.6	3.0	1.3	0.9	3.1	37	0	1.1	3.4	33.1%	6.4	12.3	51.7%	7.5	15.7	47.7%	6.9	8.5	80.7%	2.8	8.9	3.4	1.0	+163	59.0%
2018-19	64	64	33.7	27.5	13.6	3.7	1.9	0.7	3.5	58	2	1.2	4.1	30.0%	7.8	14.6	53.5%	9.1	18.7	48.4%	8.2	10.1	80.4%	2.5	11.1	3.3	1.0	+371	59.3%
2017-18	63	63	30.4	22.9	11.0	3.2	1.8	0.6	3.7	38	0	1.0	3.4	30.8%	7.0	13.4	52.7%	8.1	16.8	48.3%	5.7	7.4	76.9%	2.3	8.7	3.3	0.9	+484	57.3%
2016-17	31	31	25.4	20.2	7.8	2.1	2.5	0.9	3.8	0	0	1.2	3.2	36.7%	5.3	10.7	49.5%	6.5	13.8	46.6%	6.2	7.9	78.3%	2.0	5.9	3.6	0.6	+0	58.4%
Career	490	490	31.9	27.6	10.8	3.7	1.6	0.9	3.4	296	9	1.2	3.5	33.9%	7.9	14.7	53.9%	9.1	18.2	50.0%	8.3	9.9	83.0%	2.2	8.6	3.0	1.1	+2579	61.3%

Career Averages

PTS

REB

AST

BLK

STL

24.8

10.5

3.3

1.6

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	7	7	33.3	24.0	7.3	5.4	0.9	0.3	2.1	3	0	0.7	4.0	17.9%	7.4	13.7	54.2%	8.1	17.7	46.0%	7.0	8.4	83.1%	1.1	6.1	2.4	2.5	-51	56.0%
2023-24	6	6	41.3	33.0	10.8	5.7	1.5	1.2	4.2	4	1	2.2	6.5	33.3%	7.7	15.7	48.9%	9.8	22.2	44.4%	11.2	13.0	85.9%	3.2	7.7	3.3	1.4	+46	59.2%
2022-23	9	9	37.3	23.7	9.8	2.7	2.8	0.7	3.9	5	0	0.6	3.1	17.9%	6.8	13.9	48.8%	7.3	17.0	43.1%	8.4	9.3	90.5%	1.8	8.0	3.0	0.7	-6	56.1%
2021-22	10	10	38.5	23.6	10.7	2.1	0.8	0.4	3.2	8	0	0.7	3.3	21.2%	7.1	12.8	55.5%	7.8	16.1	48.4%	7.3	8.9	82.0%	2.1	8.6	3.4	0.7	+28	59.0%
2020-21	11	11	32.5	28.1	10.5	3.4	1.5	1.0	3.8	5	0	1.5	3.7	39.0%	7.7	14.2	54.5%	9.2	17.9	51.3%	8.3	9.9	83.5%	1.5	9.1	3.0	0.9	+121	63.1%
2019-20	4	4	36.3	30.0	12.3	1.3	1.3	1.5	3.8	4	0	1.0	4.0	25.0%	7.5	14.5	51.7%	8.5	18.5	45.9%	12.0	14.8	81.4%	2.8	9.5	4.5	0.3	-53	60.0%
2018-19	11	11	30.4	20.2	10.5	3.4	2.3	0.7	3.6	7	0	1.1	3.5	30.8%	5.1	10.9	46.7%	6.2	14.5	42.8%	6.7	8.2	82.2%	1.9	8.5	3.1	0.9	+143	55.9%
2017-18	8	8	34.8	21.4	12.6	3.0	1.8	0.9	3.6	7	0	1.0	3.6	27.6%	6.5	13.6	47.7%	7.5	17.3	43.5%	5.4	7.6	70.5%	2.9	9.8	3.9	0.8	+43	51.9%
Career	66	66	35.1	24.8	10.5	3.3	1.6	0.8	3.5	43	1	1.1	3.8	27.7%	6.9	13.4	51.1%	7.9	17.3	45.9%	7.9	9.5	82.8%	2.0	8.4	3.2	0.9	+271	57.8%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/6	SAS	L 115-102	39	34	12	1	4	0	4	6	2	33.3%	13	6	46.2%	19	8	42.1%	19	16	84.2%	5	7	0.3	-7	3	40	62.1%
4/3	MIN	W 115-103	34	19	13	7	3	0	1	6	1	16.7%	11	5	45.5%	17	6	35.3%	7	6	85.7%	2	11	7.0	+15	3	29	47.3%
3/30	MIA	L 119-109	34	26	7	3	1	0	3	6	2	33.3%	19	8	42.1%	25	10	40.0%	5	4	80.0%	1	6	1.0	-18	4	15	47.8%
3/28	CHA	W 118-114	35	29	6	2	2	0	0	6	3	50.0%	13	5	38.5%	19	8	42.1%	13	10	76.9%	0	6	0.0	+5	0	33	58.7%
3/25	CHI	W 157-137	28	35	6	7	1	0	3	3	3	100.0%	14	9	64.3%	17	12	70.6%	9	8	88.9%	0	6	2.3	+33	2	44	83.5%
2/26	MIA	W 124-117	31	26	11	4	0	1	2	6	2	33.3%	14	6	42.9%	20	8	40.0%	9	8	88.9%	1	10	2.0	+0	1	32	54.3%
2/24	IND	W 135-114	26	27	6	5	1	0	4	4	1	25.0%	13	10	76.9%	17	11	64.7%	5	4	80.0%	1	5	1.3	-1	2	30	70.3%
2/7	PHX	W 109-103	33	33	9	3	1	0	2	7	4	57.1%	12	5	41.7%	19	9	47.4%	13	11	84.6%	1	8	1.5	-10	3	35	66.7%
2/5	LAL	L 119-115	38	35	7	7	2	1	3	2	1	50.0%	17	12	70.6%	19	13	68.4%	8	8	100.0%	1	6	2.3	+7	2	49	77.7%
2/2	LAC	W 128-113	32	24	5	3	0	1	1	2	1	50.0%	17	7	41.2%	19	8	42.1%	7	7	100.0%	0	5	3.0	+2	4	22	54.3%
1/31	NOP	W 124-114	39	40	11	4	2	1	5	5	3	60.0%	22	10	45.5%	27	13	48.1%	14	11	78.6%	4	7	0.8	+16	2	38	60.3%
1/29	SAC	W 113-111	35	37	5	8	1	1	2	2	1	50.0%	19	12	63.2%	21	13	61.9%	13	10	76.9%	0	5	4.0	+9	3	44	69.2%
1/27	MIL	W 139-122	29	29	9	5	0	1	2	4	1	25.0%	20	10	50.0%	24	11	45.8%	6	6	100.0%	6	3	2.5	+6	2	27	54.4%
1/24	NYK	L 112-109	36	38	11	5	1	0	4	5	3	60.0%	16	10	62.5%	21	13	61.9%	12	9	75.0%	3	8	1.3	-3	2	45	72.3%
1/22	HOU	W 128-122	45	32	15	10	1	1	5	3	1	33.3%	16	9	56.3%	19	10	52.6%	12	11	91.7%	3	12	2.0	+21	1	53	65.9%
1/19	IND	W 113-104	33	30	9	4	0	0	1	1	1	100.0%	16	9	56.3%	17	10	58.8%	10	9	90.0%	2	7	4.0	+3	1	38	70.1%
1/16	CLE	L 117-115	33	33	5	3	1	0	1	3	2	66.7%	19	8	42.1%	22	10	45.5%	12	11	91.7%	3	2	3.0	+9	0	34	60.5%
1/14	CLE	L 133-107	24	20	4	3	1	1	6	5	2	40.0%	9	5	55.6%	14	7	50.0%	4	4	100.0%	2	2	0.5	-18	0	17	63.5%
1/12	TOR	W 115-102	35	27	8	4	0	2	7	6	1	16.7%	11	8	72.7%	17	9	52.9%	8	8	100.0%	2	6	0.6	+12	1	28	65.8%
1/9	ORL	W 103-91	31	22	9	3	1	1	4	3	0	0.0%	14	7	50.0%	17	7	41.2%	9	8	88.9%	3	6	0.8	+4	2	23	52.5%
1/7	WAS	W 131-110	25	28	7	2	2	0	2	2	1	50.0%	12	9	75.0%	14	10	71.4%	8	7	87.5%	0	7	1.0	+27	3	33	79.9%
1/5	DEN	L 125-124	40	32	10	2	1	0	6	4	1	25.0%	18	12	66.7%	22	13	59.1%	5	5	100.0%	6	4	0.3	+8	2	32	66.1%
1/3	NYK	W 130-119	33	26	10	5	0	0	3	1	0	0.0%	14	9	64.3%	15	9	60.0%	12	8	66.7%	2	8	1.7	+9	4	31	64.1%
1/1	DAL	W 123-108	35	22	4	6	1	0	2	3	0	0.0%	15	9	60.0%	18	9	50.0%	5	4	80.0%	0	4	3.0	+9	1	25	54.5%
12/30	MEM	W 139-136	38	34	10	8	2	1	4	6	1	16.7%	22	10	45.5%	28	11	39.3%	12	11	91.7%	5	5	2.0	-5	5	34	51.1%
12/26	CHI	L 109-102	32	31	5	1	1	0	2	4	2	50.0%	15	8	53.3%	19	10	52.6%	9	9	100.0%	1	4	0.5	+2	2	29	67.5%
12/23	BKN	L 114-106	31	27	6	4	2	0	3	1	1	100.0%	12	7	58.3%	13	8	61.5%	12	10	83.3%	1	5	1.3	+1	5	33	73.9%
12/14	ATL	L 120-117	30	22	14	1	2	1	3	3	1	33.3%	17	7	41.2%	20	8	40.0%	6	5	83.3%	6	8	0.3	-8	2	27	48.6%
12/12	IND	W 115-105	31	39	9	3	0	1	3	8	2	25.0%	15	10	66.7%	23	12	52.2%	18	13	72.2%	2	7	1.0	+16	3	38	63.1%
12/7	LAL	L 112-108	30	16	7	2	1	1	0	6	0	0.0%	15	4	26.7%	21	4	19.0%	8	8	100.0%	2	5	0.0	+11	1	12	32.6%
12/4	GSW	W 99-98	25	12	6	3	1	0	3	5	0	0.0%	8	5	62.5%	13	5	38.5%	2	2	100.0%	0	6	1.0	+2	1	11	43.2%
11/30	ATL	L 142-134	30	18	4	2	1	1	2	3	0	0.0%	11	6	54.5%	14	6	42.9%	8	6	75.0%	1	3	1.0	-11	2	16	51.4%
11/8	TOR	W 130-120	25	29	6	4	1	0	2	4	1	25.0%	12	9	75.0%	16	10	62.5%	9	8	88.9%	2	4	2.0	+15	3	35	72.6%
11/4	CHI	L 113-111	25	20	6	2	4	3	3	6	1	16.7%	15	6	40.0%	21	7	33.3%	6	5	83.3%	2	4	0.7	+1	2	17	42.3%
10/31	BOS	L 109-108	25	20	6	3	2	0	4	2	1	50.0%	11	5	45.5%	13	6	46.2%	7	7	100.0%	1	5	0.8	+2	2	24	62.2%
10/28	WAS	W 139-134	23	25	7	5	1	0	3	6	3	50.0%	11	6	54.5%	17	9	52.9%	6	4	66.7%	3	4	1.7	+9	4	24	63.6%
10/25	CHA	W 125-121	20	20	2	4	0	2	4	6	3	50.0%	5	4	80.0%	11	7	63.6%	5	3	60.0%	0	2	1.0	-2	0	23	75.8%
10/22	BOS	W 117-116	20	4	6	2	1	0	0	4	0	0.0%	5	1	20.0%	9	1	11.1%	2	2	100.0%	1	5	0.0	-16	2	4	20.2%
Regular Season Totals			31.6	26.9	7.7	3.9	1.2	0.6	2.9	4.2	1.4	33.3%	14.2	7.6	53.5%	18.3	9.0	48.9%	8.8	7.5	85.4%	2.0	5.7	1.4	+155	2.2	32.8	60.5%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/10	NYK	L 144-114	27	24	5	4	0	0	3	2	2	100.0%	6	6	100.0%	8	8	100.0%	7	6	85.7%	1	4	1.3	-24	3	30	108.3%
5/8	NYK	L 108-94	34	18	6	5	3	0	3	4	0	0.0%	13	7	53.8%	17	7	41.2%	6	4	66.7%	1	5	1.7	-9	3	20	45.8%
5/4	NYK	L 137-98	24	14	4	1	0	0	1	2	0	0.0%	9	3	33.3%	11	3	27.3%	9	8	88.9%	0	4	1.0	-24	1	14	46.8%
5/2	BOS	W 109-100	39	34	12	6	1	0	1	4	1	25.0%	22	11	50.0%	26	12	46.2%	11	9	81.8%	2	10	6.0	+11	2	45	55.1%
4/30	BOS	W 106-93	34	19	10	8	0	1	1	5	1	20.0%	13	5	38.5%	18	6	33.3%	7	6	85.7%	1	9	8.0	+7	2	26	45.1%
4/28	BOS	W 113-97	38	33	4	8	1	0	3	5	0	0.0%	18	12	66.7%	23	12	52.2%	10	9	90.0%	1	3	2.7	+13	4	32	60.2%
4/26	BOS	L 128-96	34	26	10	6	1	1	3	6	1	16.7%	15	8	53.3%	21	9	42.9%	9	7	77.8%	2	8	2.0	-25	2	33	52.1%
Postseason Totals			33.3	24.0	7.3	5.4	0.9	0.3	2.1	4.0	0.7	17.9%	13.7	7.4	54.2%	17.7	8.1	46.0%	8.4	7.0	83.1%	1.1	6.1	2.5	-51	2.4	31.9	56.0%

Joel Embiid: Breaking News

Embiid logged 24 points (8-8 FG, 2-2 3Pt, 6-7 FT), five rebounds and four assists in 27 minutes during Sunday's 144-114 loss to New York in Game 4 of the Eastern Conference Semifinals. Embiid was a bright spot for the 76ers in Sunday's season-ending defeat, as he shot a perfect 8-for-8 from the floor. Embiid was clearly laboring throughout the second-round series, missing Game 2 and failing to produce at the level he did in the opening round against Boston. The star big man averaged 18.7 points, 5.0 rebounds, 3.3 assists and 1.0 blocks across 29.0 minutes per contest in three Eastern Conference Semifinals appearances.

Embiid (hip) is available for Sunday's Game 4 of the Eastern Conference Semifinals against the Knicks. Embiid will shake off his probable tag due to right hip soreness and suit up in Sunday's do-or-die matchup. The star big man has struggled through two appearances in the series, during which he has averaged 16.0 points, 5.0 rebounds, 3.0 assists and 1.5 blocks while shooting 35.7 percent from the field in 30.0 minutes per contest.

Embiid (hip) is listed as probable for Sunday's Game 4 against the Knicks. Embiid was unable to play in Game 2 due to an ankle injury. He returned for Game 3 on Friday and played 35 minutes in a 108-94 loss, and while he's now dealing with a hip issue, the injury doesn't appear to be severe enough for him to miss Sunday's do-or-die contest. Embiid has averaged 24.0 points, 7.7 rebounds, 5.7 assists and 1.0 blocks over 34.3 minutes per game across six postseason contests.